Semi-annual Report for 2026
Filed with SSE · · 176 pages · Chinese
North China Pharmaceutical Company Ltd. on 6ix
Earlier from North China Pharmaceutical
- Announcement on Resignation of Senior Management
- Announcement on the Proposed Selection of Drugs of the Company and Its Subsidiaries in the National Centralized Drug Procurement
- Announcement on Inclusion of Products of the Company and Its Subsidiaries in the National Essential Medicines List
- Announcement on Obtaining Drug Registration Certificate
- Announcement on Implementation of Dividend Distribution for 2025
Later from North China Pharmaceutical
- Announcement on Obtaining Notice of Approval for Drug Supplementary Application by a Subordinate Company
- Announcement on Providing Guarantees for Subsidiaries
- Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Hebei Jurisdiction and 2026 Semi-annual Collective Performance Briefing
- (600812)"North China Pharmaceutical Company Ltd."Announcement on Abnormal Fluctuations in Stock Trading
- (600812)"North China Pharmaceutical Company Ltd."Announcement on Risk Warning in Stock Trading
Follow North China Pharmaceutical into a list and get an email when it puts out news.
Follow North China Pharmaceutical